1. Home
  2. MFA vs AMPH Comparison

MFA vs AMPH Comparison

Compare MFA & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFA Financial Inc.

MFA

MFA Financial Inc.

HOLD

Current Price

$9.63

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$18.72

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFA
AMPH
Founded
1997
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
971.8M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
MFA
AMPH
Price
$9.63
$18.72
Analyst Decision
Buy
Buy
Analyst Count
6
8
Target Price
$11.05
$28.38
AVG Volume (30 Days)
1.3M
710.6K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
14.16%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
N/A
$719,887,000.00
Revenue This Year
N/A
$6.90
Revenue Next Year
$10.02
$4.64
P/E Ratio
$7.75
$137.93
Revenue Growth
N/A
N/A
52 Week Low
$8.78
$16.65
52 Week High
$10.57
$31.26

Technical Indicators

Market Signals
Indicator
MFA
AMPH
Relative Strength Index (RSI) 46.59 44.87
Support Level $9.37 $16.84
Resistance Level $9.70 $20.08
Average True Range (ATR) 0.15 0.80
MACD 0.01 0.11
Stochastic Oscillator 46.69 73.53

Price Performance

Historical Comparison
MFA
AMPH

About MFA MFA Financial Inc.

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: